Novo Nordisk invests in new purification pilot plant in Denmark
| By Gerald Ondrey
Novo Nordisk A/S (Bagsværd, Denmark; www.novonordisk.com) is increasing its drug development capacity by investing 550 million Danish kroner ($100 million) in a new research and development facility in Bagsværd, Denmark.
The purification plant…